tiprankstipranks
ANI Pharmaceuticals sees ‘substantial accretion’ from Alimera Sciences deal
PremiumThe FlyANI Pharmaceuticals sees ‘substantial accretion’ from Alimera Sciences deal
9d ago
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
PremiumPress Releases
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
9d ago
ANI Pharmaceuticals to acquire Alimera Sciences for $381M upfront
PremiumThe Fly
ANI Pharmaceuticals to acquire Alimera Sciences for $381M upfront
9d ago
ANI Pharmaceuticals Financial Health Overview Released
PremiumCompany AnnouncementsANI Pharmaceuticals Financial Health Overview Released
2M ago
ANI Pharmaceuticals price target raised to $87 from $83 at H.C. Wainwright
PremiumThe Fly
ANI Pharmaceuticals price target raised to $87 from $83 at H.C. Wainwright
2M ago
ANI Pharmaceuticals sees 2024 adjusted EPS $4.26-$4.67, consensus $4.48
PremiumThe Fly
ANI Pharmaceuticals sees 2024 adjusted EPS $4.26-$4.67, consensus $4.48
2M ago
ANI Pharmaceuticals Financial Report: Key Insights Revealed
PremiumCompany AnnouncementsANI Pharmaceuticals Financial Report: Key Insights Revealed
3M ago
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
PremiumPress Releases
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
3M ago
ANI Pharmaceuticals announces launch of Baclofen Oral Suspension
PremiumThe Fly
ANI Pharmaceuticals announces launch of Baclofen Oral Suspension
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100